ProCE Banner Activity

Frequently Asked Questions About Addressing Social Determinants of Health in NVAF

Clinical Thought

Expert faculty answer key questions posed during a live webinar addressing social determinants of health in nonvalvular atrial fibrillation (NVAF).

Released: May 26, 2022

Expiration: May 25, 2023



Keith C. Ferdinand

Keith C. Ferdinand, MD, FACC, FAHA

Professor of Medicine
Tulane Heart and Vascular Institute
Tulane University School of Medicine
New Orleans, Louisiana

David S. Kountz

David S. Kountz, MD, MBA, MACP

Department of Medicine
Hackensack Meridian School of Medicine
Nutley, New Jersey

Laura Ross

Laura Ross, PA-C, MPAS, CLS, DipACLM, AACC

Director, Heart Disease Prevention and Lipid Clinic
Park Nicollet Heart and Vascular Center
St Louis Park, Minnesota


This activity is supported by educational grants from Bristol Myers Squibb and Pfizer Alliance Grant.

Provided by

ProCE Banner
ProCE Banner


This activity is supported by an educational grant from Bristol Myers Squibb and Pfizer Alliance.

Bristol Myers Squibb

Pfizer Alliance



ProCE Banner

Target Audience

This program is intended for cardiologists, primary care physicians, physician assistants, nurse practitioners, and other healthcare professionals who care for patients with nonvalvular atrial fibrillation.


All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose to the audience all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.

Keith C. Ferdinand, MD, FACC, FAHA, has disclosed that he has received consulting fees from Amgen, Boehringer Ingelheim, Medtronic, Novartis, and Sanofi.

David S. Kountz, MD, has no relevant conflicts of interest to report.

Laura Ross, PA-C, CLS, has no relevant conflicts of interest to report.

None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose.


Clinical Thought


The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.

Additional Information

Program Medium

This program has been made available online.